WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006091763) ULTRASONICALLY ASSISTED DERMAL OR TRANSDERMAL DELIVERY SUBSTANCE PREPARATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/091763    International Application No.:    PCT/US2006/006509
Publication Date: 31.08.2006 International Filing Date: 24.02.2006
IPC:
A61F 13/00 (2006.01)
Applicants: DERMISONICS, INC. [US/US]; FOUR TOWER BRIDGE, 200 Bar-harbor Drive, West Conshohocken, Pennsylvania 19428 (US) (For All Designated States Except US).
REDDING, Bruce [US/GB]; (US) (For US Only)
Inventors: REDDING, Bruce; (US)
Agent: DARCY, Jonathan; PLEVY, HOWARD & DARCY, PC, P.o. Box 226, Fort Washington, Pennsylvania 19034 (US)
Priority Data:
60/655,381 24.02.2005 US
Title (EN) ULTRASONICALLY ASSISTED DERMAL OR TRANSDERMAL DELIVERY SUBSTANCE PREPARATION
(FR) PREPARATION DE SUBSTANCE POUR ADMINISTRATION TRANSDERMIQUE OU DERMIQUE ASSISTEE AUX ULTRASONS
Abstract: front page image
(EN)A method for improving transdermal delivery of an active ingredient in a formulation made in accordance with a dibasic sodium phosphate containing formula responsively to insonification thereof, including: reducing the amount of dibasic sodium phosphate in the formula to provide a reduced dibasic sodium phosphate formula; and, making a formulation in accordance with the reduced dibasic sodium phosphate formula.
(FR)L'invention concerne un procédé permettant d'améliorer l'administration transdermique d'un ingrédient actif dans une formulation fabriquée conforme à une formule contenant du phosphate de sodium dibasique en réponse à son insonification, ledit procédé consistant à réduire la quantité de phosphate de sodium dibasique dans la formule pour produire une formule à phosphate de sodium dibasique réduit; et à élaborer une formulation conforme à la formule à phosphate de sodium dibasique réduit.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)